Umbilical & Placental Cell News Volume 14.41 | Oct 20 2022

    0
    115








    2022-10-20 | UPCN 14.41


    Umbilical-and-Placental-Cell-News-email-header (1)
    Vol. 14.41 – 20 October, 2022
    TOP STORY

    Secretome of Human Umbilical Cord Mesenchymal Stem Cell Maintains Skin Homeostasis by Regulating Multiple Skin Physiological Function

    Researchers evaluated the therapeutic potential of the secretome of human umbilical cord MSCs for dermatological diseases in adult human skin cells, ex vivo skin tissue, and a 3D skin model.
    [Cell and Tissue Research]

    Abstract

    Banner Ad Cross Reference Banner Ad Cross Reference 100% 10 E17 Visit the Hematopoiesis Resource Center for videos, tips, and protocols to help with your research questions. Screen reader support enabled. Visit the Hematopoiesis Resource Center for videos, tips, and protocols to help with your research questions. Turn on screen reader support
    PUBLICATIONSRanked by the impact factor of the journal

    Naïve Pluripotent-Like Characteristics of Non-Tumorigenic Muse Cells Isolated from Human Amniotic Membrane

    SSEA-3(+) cells from human amniotic membrane MSCs were compared with human bone marrow-multilineage-differentiating stress-enduring (Muse) cells, in order to investigate similarities and differences of key charachteristics between the two cell types.
    [Scientific Reports]

    Full Article

    Therapeutic Effect of Human Umbilical Cord Mesenchymal Stem Cells in Early Traumatic Osteonecrosis of the Femoral Head

    The authors explored the available evidence for the therapeutic effect of human umbilical cord MSCs on early-stage traumatic osteonecrosis of the femoral head.
    [Journal of Orthopaedic Translation]

    Full Article

    Galangin Induces the Osteogenic Differentiation of Human Amniotic Mesenchymal Stem Cells via the JAK2/STAT3 Signaling Pathway

    Scientists explored the potential pro-osteogenic differentiation effect of galangin, a flavonoid derived from Alpinia officinarum, on human amniotic MSCs and the underlying molecular mechanism.
    [European Journal of Pharmacology]

    AbstractGraphical Abstract

    Gelatin Microspheres Loaded with Wharton’s Jelly Mesenchymal Stem Cells Promote Acute Full-Thickness Skin Wound Healing and Regeneration in Mice

    3D gelatin microspheres (GM) had strong biocompatibility, and in comparison with two-dimensional adherent culturing, GM loading increased the cell viability, and proliferation ability of Wharton’s jelly MSCs.
    [Advances in Wound Care]

    Abstract

    Differentiation of Human Wharton Jelly Mesenchymal Stem Cells into Germ-Like Cells; Emphasis on Evaluation of Germ-Long Non-coding RNAs

    Investigators developed a modified differentiation process and identified a panel of GermlncRNAs related to germ-like cells.
    [Molecular Biology Reports]

    Abstract
    Kevin Shoulars found a faster, more reproducible way to assess the potency of core blood units for transplant. Watch the webinar.
    REVIEWS

    Amniotic Stem Cells as a Source of Regenerative Medicine to Treat Female Infertility

    The authors summarize the current standing and progress of human amniotic epithelial stem cells, amniotic MSCs, and amniotic fluid stem cells in the field of reproductive medicine.
    [Human Cell]

    Full Article

    Ex Vivo Perfusion of the Human Placenta to Investigate Pregnancy Pathologies

    Investigators review the key studies which have utilized the ex vivo placenta perfusion model to study different aspects of such pregnancy pathologies.
    [Placenta]

    Full Article
    INDUSTRY AND POLICY NEWS

    Smart Immune and Greater Paris University Hospitals (AP-HP) Begin Groundbreaking Phase I/II Trial with ProTcellâ„¢, a Thymus-Empowered T Cell Therapy Platform, in Adults with Blood Cancers

    Smart Immune SAS announced that SMART102, a human T-lymphoid progenitor cell injection derived from cord blood using SmartImmune’s ProTcell™ platform, has entered clinical testing in a trial sponsored and led by Great Paris University Hospitals.
    [Smart Immune SAS]

    Press Release
    FEATURED EVENT

    Emerging Cellular Therapies at the Forefront of Cancer Immunotherapy

    January 29 – February 2, 2023
    Banff, Alberta, Canada

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Position – Computational Biology

    Beth Israel Deaconess Medical Center – Boston, Massachusetts, United States

    Postdoctoral Fellow and Research Associate – Obstetrics and Gynecology

    University of Maryland School of Medicine – Baltimore, Maryland, United States

    Manager – Laboratory Services

    STEMCELL Technologies – Vancouver, British Columbia, Canada

    Postdoctoral Scholar – Stem Cell-Based Therapy

    UCLA Jules Stein Eye Institute – Los Angeles, California, United States

    Assistant/Associate Faculty Position – Cancer Research

    University of Colorado Denver – Aurora, Colorado, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cord Blood News Twitter